D-0007-2017 Class III Terminated
FDA drug recall D-0007-2017 was initiated by Sun Pharmaceutical Industries, Inc. on Sep 13, 2016 and is designated Class III. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Jul 2, 2018). Affected quantity: 31,762 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 12, 2016
- Initiation Date
- Sep 13, 2016
- Termination Date
- Jul 2, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 31,762 bottles
Product description
buPROPion Hydrochloride Extended-release Tablets, USP (SR), 150 mg, Twice-A-Day, in 60 count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 Manufactured by Sun Pharmaceuticals Ind. Ltd. Halol- Baroda Highway, Halol-389 350, Gujarat, India. UPC 347335737868 NDC 47335-737-86
Reason for recall
Failed Dissolution Specifications
Distribution pattern
Nationwide
Code information
JKN5124A and JKN5229A, exp 10/2016
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0007-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026